Open-mkt buys · 90d
$50.1K
2 trades · 1 insiders
Open-mkt sales · 90d
$2.36M
7 trades · 4 insiders
Net · 90d
$-2.31M
Insiders on file
28
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | Other | 2 | $14.25M | $1.74M | 2026-10-29 |
| Ben Yong | Director | 10 | $0 | $31.4K | 2026-09-14 |
| Nicacio Leonardo Viana | Chief Medical Officer | 4 | $0 | $0 | 2026-08-16 |
| Saxena Nishant C | Chief Business Officer | 6 | $151.3K | $0 | 2026-08-11 |
| Cohen Yuval | Chief Executive Officer, Director | 81 | $159.4K | $3.94M | 2026-08-07 |
| Moran Sean F. | Chief Financial Officer | 98 | $1.20M | $1.66M | 2026-08-07 |
| Altmeyer Anne | Director | 13 | $0 | $50.9K | 2026-06-10 |
| Jenkins John Kenneth | Director | 16 | $7.0K | $58.4K | 2026-06-10 |
| Kung Winston | Director | 7 | $0 | $16.0K | 2026-06-10 |
| Pfeiffenberger Brent | Director | 2 | $0 | $0 | 2026-05-19 |
| Jacques Rachelle Suzanne | Director | 13 | $0 | $0 | 2026-05-19 |
| Smethurst Dominic | Chief Medical Officer | 9 | $0 | $120.5K | 2026-03-02 |
| Hodgson Ian | Chief Operating Officer | 4 | $0 | $25.8K | 2026-02-17 |
| Chen Bihua | 10% Owner | 25 | $32.44M | $344.1K | 2025-12-11 |
| HOLMER ALAN F | Director | 23 | $12.5K | $0 | 2025-05-30 |
| Cormorant Global Healthcare Master Fund, LP | 10% Owner | 6 | $7.00M | $0 | 2024-09-20 |
| Salzmann Peter | Director | 8 | $0 | $0 | 2024-05-30 |
| CATLIN AVERY W | Director | 19 | $146.3K | $0 | 2024-05-30 |
| Brake Rachael Louise | Chief Scientific Officer | 3 | $0 | $0 | 2023-02-13 |
| Millian Craig Stuart | Chief Operating Officer | 14 | $76.5K | $0 | 2023-02-13 |
| White Barbara | Chief Medical Officer | 37 | $689.4K | $0 | 2021-02-02 |
| Golumbeski George | Director | 1 | $0 | $0 | 2020-07-06 |
| Hochman David P | Director | 31 | $327.7K | $0 | 2020-05-20 |
| Discordia Robert Paul | Chief Operating Officer | 5 | $109.5K | $0 | 2020-03-17 |
| Panayiotopoulos Paris | Director | 4 | $100.4K | $0 | 2019-05-22 |
| Tepper Mark | President and CSO | 8 | $6.1K | $0 | 2019-01-18 |
| GUPTA RENU | Director | 6 | $34.0K | $0 | 2017-05-25 |
| Burstein Sumner | Other | 11 | $0 | $692.6K | 2015-11-16 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP | Other | S Sale | 2026-10-29 | 2026-11-02 | 425,000 | $4.10 | $1.74M | 1,919,971 | SEC↗ |
| Ben Yong | Director | S Sale | 2026-09-14 | 2026-09-15 | 2,000 | $7.84 | $15.7K | 9,383 | SEC↗ |
| Ben Yong | Director | S Sale | 2026-09-14 | 2026-09-15 | 2,000 | $7.84 | $15.7K | 9,383 | SEC↗ |
| Nicacio Leonardo Viana | Chief Medical Officer | A Award deriv | 2026-08-16 | 2026-08-17 | 191,676 | — | $0 | 191,676 | SEC↗ |
| Nicacio Leonardo Viana | Chief Medical Officer | A Award | 2026-08-16 | 2026-08-17 | 58,333 | — | $0 | 58,333 | SEC↗ |
| Nicacio Leonardo Viana | Chief Medical Officer | A Award deriv | 2026-08-16 | 2026-08-17 | 191,676 | — | $0 | 191,676 | SEC↗ |
| Nicacio Leonardo Viana | Chief Medical Officer | A Award | 2026-08-16 | 2026-08-17 | 58,333 | — | $0 | 58,333 | SEC↗ |
| Saxena Nishant C | Chief Business Officer | P Buy | 2026-08-11 | 2026-08-12 | 2,600 | $9.63 | $25.0K | 77,900 | SEC↗ |
| Saxena Nishant C | Chief Business Officer | P Buy | 2026-08-11 | 2026-08-12 | 2,600 | $9.63 | $25.0K | 77,900 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | S Sale | 2026-08-07 | 2026-08-10 | 12,000 | $10.08 | $121.0K | 84,694 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | S Sale | 2026-08-07 | 2026-08-10 | 17,000 | $10.08 | $171.4K | 157,316 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | S Sale | 2026-08-07 | 2026-08-10 | 12,000 | $10.08 | $121.0K | 84,694 | SEC↗ |
| Cohen Yuval | Chief Executive Officer, Dir | S Sale | 2026-08-07 | 2026-08-10 | 17,000 | $10.08 | $171.4K | 157,316 | SEC↗ |
| Altmeyer Anne | Director | S Sale | 2026-06-10 | 2026-06-11 | 2,412 | $7.91 | $19.1K | 7,579 | SEC↗ |
| Jenkins John Kenneth | Director | S Sale | 2026-06-10 | 2026-06-11 | 4,800 | $7.91 | $38.0K | 3,833 | SEC↗ |
| Kung Winston | Director | S Sale | 2026-06-10 | 2026-06-11 | 2,026 | $7.91 | $16.0K | 12,140 | SEC↗ |
| Saxena Nishant C | Chief Business Officer | P Buy | 2026-06-03 | 2026-06-03 | 9,000 | $7.58 | $68.2K | 75,300 | SEC↗ |
| Saxena Nishant C | Chief Business Officer | P Buy | 2026-06-02 | 2026-06-03 | 4,500 | $7.33 | $33.0K | 66,300 | SEC↗ |
| Saxena Nishant C | Chief Business Officer | A Award deriv | 2026-05-21 | 2026-05-22 | 192,300 | — | $0 | 192,300 | SEC↗ |
| Saxena Nishant C | Chief Business Officer | A Award | 2026-05-21 | 2026-05-22 | 58,300 | — | $0 | 61,800 | SEC↗ |
| Pfeiffenberger Brent | Director | A Award deriv | 2026-05-19 | 2026-05-21 | 24,700 | — | $0 | 24,700 | SEC↗ |
| Ben Yong | Director | A Award deriv | 2026-05-19 | 2026-05-21 | 12,300 | — | $0 | 12,300 | SEC↗ |
| Altmeyer Anne | Director | A Award deriv | 2026-05-19 | 2026-05-21 | 12,300 | — | $0 | 12,300 | SEC↗ |
| Jenkins John Kenneth | Director | A Award deriv | 2026-05-19 | 2026-05-21 | 12,300 | — | $0 | 12,300 | SEC↗ |
| Jacques Rachelle Suzanne | Director | A Award deriv | 2026-05-19 | 2026-05-21 | 12,300 | — | $0 | 12,300 | SEC↗ |
| Kung Winston | Director | A Award deriv | 2026-05-19 | 2026-05-21 | 12,300 | — | $0 | 12,300 | SEC↗ |
| Pfeiffenberger Brent | Director | A Award | 2026-05-19 | 2026-05-21 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Ben Yong | Director | A Award | 2026-05-19 | 2026-05-21 | 3,800 | — | $0 | 11,383 | SEC↗ |
| Altmeyer Anne | Director | A Award | 2026-05-19 | 2026-05-21 | 3,800 | — | $0 | 9,991 | SEC↗ |
| Jenkins John Kenneth | Director | A Award | 2026-05-19 | 2026-05-21 | 3,800 | — | $0 | 8,633 | SEC↗ |
| Jacques Rachelle Suzanne | Director | A Award | 2026-05-19 | 2026-05-21 | 3,800 | — | $0 | 11,383 | SEC↗ |
| Kung Winston | Director | A Award | 2026-05-19 | 2026-05-21 | 3,800 | — | $0 | 14,166 | SEC↗ |
| Smethurst Dominic | Chief Medical Officer | S Sale | 2026-03-02 | 2026-03-04 | 6,097 | $8.30 | $50.6K | 89,790 | SEC↗ |
| Hodgson Ian | Chief Operating Officer | S Sale | 2026-02-17 | 2026-02-18 | 847 | $7.38 | $6.3K | 51,080 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | S Sale | 2026-02-13 | 2026-02-18 | 13,871 | $7.78 | $107.9K | 174,316 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | S Sale | 2026-02-13 | 2026-02-18 | 4,701 | $7.78 | $36.6K | 96,694 | SEC↗ |
| Hodgson Ian | Chief Operating Officer | S Sale | 2026-02-03 | 2026-02-04 | 2,415 | $8.09 | $19.5K | 51,927 | SEC↗ |
| Smethurst Dominic | Chief Medical Officer | S Sale | 2026-02-03 | 2026-02-04 | 3,285 | $8.09 | $26.6K | 95,887 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | A Award deriv | 2026-01-14 | 2026-01-16 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | A Award deriv | 2026-01-14 | 2026-01-16 | 84,247 | — | $0 | 84,247 | SEC↗ |
| Smethurst Dominic | Chief Medical Officer | A Award deriv | 2026-01-14 | 2026-01-16 | 85,095 | — | $0 | 85,095 | SEC↗ |
| Hodgson Ian | Chief Operating Officer | A Award deriv | 2026-01-14 | 2026-01-16 | 85,095 | — | $0 | 85,095 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | A Award | 2026-01-14 | 2026-01-16 | 50,000 | — | $0 | 188,187 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | A Award | 2026-01-14 | 2026-01-16 | 28,082 | — | $0 | 101,395 | SEC↗ |
| Smethurst Dominic | Chief Medical Officer | A Award | 2026-01-14 | 2026-01-16 | 28,365 | — | $0 | 99,172 | SEC↗ |
| Hodgson Ian | Chief Operating Officer | A Award | 2026-01-14 | 2026-01-16 | 28,365 | — | $0 | 54,342 | SEC↗ |
| Chen Bihua | 10% Owner | S Sale | 2025-12-11 | 2025-12-15 | 30,029 | $11.46 | $344.1K | 2,344,971 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | M Exercise deriv | 2025-10-27 | 2025-10-27 | 8,973 | — | $0 | 22,106 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | M Exercise | 2025-10-27 | 2025-10-27 | 8,973 | $4.26 | $38.2K | 147,160 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | S Sale | 2025-10-27 | 2025-10-27 | 8,973 | $17.14 | $153.8K | 138,187 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | M Exercise deriv | 2025-10-24 | 2025-10-27 | 12,981 | — | $0 | 10,386 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | M Exercise deriv | 2025-10-24 | 2025-10-27 | 18,660 | — | $0 | 31,079 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | M Exercise | 2025-10-24 | 2025-10-27 | 12,981 | $4.26 | $55.3K | 86,294 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | S Sale | 2025-10-24 | 2025-10-27 | 12,981 | $17.02 | $220.9K | 73,313 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | M Exercise | 2025-10-24 | 2025-10-27 | 18,660 | $4.26 | $79.5K | 156,847 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | S Sale | 2025-10-24 | 2025-10-27 | 18,660 | $17.01 | $317.4K | 138,187 | SEC↗ |
| Altmeyer Anne | Director | M Exercise deriv | 2025-10-20 | 2025-10-21 | 1,060 | — | $0 | 4,247 | SEC↗ |
| Altmeyer Anne | Director | S Sale | 2025-10-20 | 2025-10-21 | 1,060 | $20.50 | $21.7K | 6,191 | SEC↗ |
| Altmeyer Anne | Director | M Exercise | 2025-10-20 | 2025-10-21 | 1,060 | $4.80 | $5.1K | 7,251 | SEC↗ |
| Jacques Rachelle Suzanne | Director | A Award deriv | 2025-05-30 | 2025-06-02 | 16,000 | — | $0 | 16,000 | SEC↗ |
| HOLMER ALAN F | Director | A Award deriv | 2025-05-30 | 2025-06-02 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Altmeyer Anne | Director | A Award deriv | 2025-05-30 | 2025-06-02 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Ben Yong | Director | A Award deriv | 2025-05-30 | 2025-06-02 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Jenkins John Kenneth | Director | A Award deriv | 2025-05-30 | 2025-06-02 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Kung Winston | Director | A Award deriv | 2025-05-30 | 2025-06-02 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Jacques Rachelle Suzanne | Director | A Award | 2025-05-30 | 2025-06-02 | 4,800 | — | $0 | 7,583 | SEC↗ |
| HOLMER ALAN F | Director | A Award | 2025-05-30 | 2025-06-02 | 4,800 | — | $0 | 10,629 | SEC↗ |
| Altmeyer Anne | Director | A Award | 2025-05-30 | 2025-06-02 | 4,800 | — | $0 | 6,191 | SEC↗ |
| Altmeyer Anne | Director | S Sale | 2025-05-30 | 2025-06-02 | 1,392 | $7.25 | $10.1K | 1,391 | SEC↗ |
| Ben Yong | Director | A Award | 2025-05-30 | 2025-06-02 | 4,800 | — | $0 | 7,583 | SEC↗ |
| Jenkins John Kenneth | Director | S Sale | 2025-05-30 | 2025-06-02 | 2,783 | $7.35 | $20.5K | 33 | SEC↗ |
| Jenkins John Kenneth | Director | A Award | 2025-05-30 | 2025-06-02 | 4,800 | — | $0 | 4,833 | SEC↗ |
| Kung Winston | Director | A Award | 2025-05-30 | 2025-06-02 | 4,800 | — | $0 | 10,366 | SEC↗ |
| Smethurst Dominic | Chief Medical Officer | S Sale | 2025-03-06 | 2025-03-07 | 6,393 | $6.78 | $43.3K | 70,807 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | S Sale | 2025-02-14 | 2025-02-18 | 7,134 | $8.76 | $62.5K | 138,187 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | S Sale | 2025-02-14 | 2025-02-18 | 2,792 | $8.76 | $24.5K | 73,313 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | A Award deriv | 2025-01-31 | 2025-02-04 | 228,800 | — | $0 | 228,800 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | A Award deriv | 2025-01-31 | 2025-02-04 | 92,500 | — | $0 | 92,500 | SEC↗ |
| Smethurst Dominic | Chief Medical Officer | A Award deriv | 2025-01-31 | 2025-02-04 | 91,200 | — | $0 | 91,200 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | A Award | 2025-01-31 | 2025-02-04 | 68,100 | — | $0 | 145,321 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | A Award | 2025-01-31 | 2025-02-04 | 27,500 | — | $0 | 76,105 | SEC↗ |
| Smethurst Dominic | Chief Medical Officer | A Award | 2025-01-31 | 2025-02-04 | 27,200 | — | $0 | 77,200 | SEC↗ |
| Cormorant Global Healthcare Ma | 10% Owner | P Buy | 2024-09-20 | 2024-09-24 | 47,564 | $21.47 | $1.02M | 2,349,231 | SEC↗ |
| Cormorant Global Healthcare Ma | 10% Owner | P Buy | 2024-09-20 | 2024-09-24 | 66,088 | $19.61 | $1.30M | 2,162,116 | SEC↗ |
| Cormorant Global Healthcare Ma | 10% Owner | P Buy | 2024-09-20 | 2024-09-24 | 139,551 | $20.42 | $2.85M | 2,301,667 | SEC↗ |
| Cormorant Global Healthcare Ma | 10% Owner | P Buy | 2024-09-20 | 2024-09-24 | 25,769 | $22.23 | $572.8K | 2,375,000 | SEC↗ |
| Cormorant Global Healthcare Ma | 10% Owner | P Buy | 2024-09-20 | 2024-09-24 | 45,085 | $17.48 | $788.1K | 2,070,085 | SEC↗ |
| Cormorant Global Healthcare Ma | 10% Owner | P Buy | 2024-09-20 | 2024-09-24 | 25,943 | $18.36 | $476.3K | 2,096,028 | SEC↗ |
| Kung Winston | Director | A Award deriv | 2024-08-16 | 2024-08-20 | 5,566 | — | $0 | 5,566 | SEC↗ |
| Kung Winston | Director | A Award | 2024-08-16 | 2024-08-20 | 5,566 | — | $0 | 5,566 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | M Exercise deriv | 2024-06-18 | 2024-06-18 | 1,770 | — | $0 | 31,057 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | M Exercise deriv | 2024-06-18 | 2024-06-18 | 11,667 | — | $0 | 0 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | M Exercise deriv | 2024-06-18 | 2024-06-18 | 2,322 | — | $0 | 49,739 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | M Exercise deriv | 2024-06-18 | 2024-06-18 | 1,958 | — | $0 | 0 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | S Sale | 2024-06-18 | 2024-06-18 | 7,179 | $42.24 | $303.2K | 77,221 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | M Exercise | 2024-06-18 | 2024-06-18 | 1,770 | $14.10 | $25.0K | 86,170 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | S Sale | 2024-06-18 | 2024-06-18 | 1,770 | $42.24 | $74.8K | 84,400 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | M Exercise | 2024-06-18 | 2024-06-18 | 2,322 | $4.26 | $9.9K | 86,722 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | S Sale | 2024-06-18 | 2024-06-18 | 2,322 | $42.24 | $98.1K | 84,400 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | S Sale | 2024-06-18 | 2024-06-18 | 11,667 | $42.24 | $492.8K | 84,400 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | M Exercise | 2024-06-18 | 2024-06-18 | 11,667 | $30.00 | $350.0K | 96,067 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | S Sale | 2024-06-18 | 2024-06-18 | 1,958 | $42.12 | $82.5K | 48,605 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | M Exercise | 2024-06-18 | 2024-06-18 | 1,958 | $30.00 | $58.7K | 50,563 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | M Exercise deriv | 2024-06-17 | 2024-06-18 | 1,770 | — | $0 | 52,061 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | M Exercise deriv | 2024-06-17 | 2024-06-18 | 9,333 | — | $0 | 11,667 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | M Exercise deriv | 2024-06-17 | 2024-06-18 | 6,730 | — | $0 | 11,217 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | M Exercise | 2024-06-17 | 2024-06-18 | 9,333 | $30.00 | $280.0K | 93,733 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | S Sale | 2024-06-17 | 2024-06-18 | 1,770 | $46.02 | $81.5K | 84,400 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | S Sale | 2024-06-17 | 2024-06-18 | 9,333 | $46.02 | $429.5K | 84,400 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | M Exercise | 2024-06-17 | 2024-06-18 | 1,770 | $4.26 | $7.5K | 86,170 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | M Exercise | 2024-06-17 | 2024-06-18 | 6,730 | $14.10 | $94.9K | 55,335 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | S Sale | 2024-06-17 | 2024-06-18 | 6,730 | $46.77 | $314.8K | 48,605 | SEC↗ |
| HOLMER ALAN F | Director | M Exercise deriv | 2024-06-14 | 2024-06-14 | 1,667 | — | $0 | 0 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | M Exercise deriv | 2024-06-14 | 2024-06-18 | 12,487 | — | $0 | 53,831 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | M Exercise deriv | 2024-06-14 | 2024-06-18 | 16,830 | — | $0 | 32,827 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | M Exercise deriv | 2024-06-14 | 2024-06-18 | 1,567 | — | $0 | 1,958 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | M Exercise deriv | 2024-06-14 | 2024-06-18 | 7,788 | — | $0 | 23,367 | SEC↗ |
| HOLMER ALAN F | Director | M Exercise | 2024-06-14 | 2024-06-14 | 1,667 | $30.00 | $50.0K | 5,829 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | M Exercise | 2024-06-14 | 2024-06-18 | 16,830 | $14.10 | $237.3K | 101,230 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | S Sale | 2024-06-14 | 2024-06-18 | 16,830 | $50.17 | $844.4K | 84,400 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | M Exercise | 2024-06-14 | 2024-06-18 | 12,487 | $4.26 | $53.2K | 96,887 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | S Sale | 2024-06-14 | 2024-06-18 | 12,487 | $50.17 | $626.5K | 84,400 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | M Exercise | 2024-06-14 | 2024-06-18 | 7,788 | $4.26 | $33.2K | 56,393 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | M Exercise | 2024-06-14 | 2024-06-18 | 1,567 | $30.00 | $47.0K | 50,172 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | S Sale | 2024-06-14 | 2024-06-18 | 1,567 | $49.87 | $78.1K | 48,605 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | S Sale | 2024-06-14 | 2024-06-18 | 7,788 | $49.87 | $388.4K | 48,605 | SEC↗ |
| Altmeyer Anne | Director | A Award | 2024-05-30 | 2024-06-03 | 2,783 | — | $0 | 2,783 | SEC↗ |
| HOLMER ALAN F | Director | A Award | 2024-05-30 | 2024-06-03 | 2,783 | — | $0 | 4,162 | SEC↗ |
| Ben Yong | Director | A Award | 2024-05-30 | 2024-06-03 | 2,783 | — | $0 | 2,783 | SEC↗ |
| Jacques Rachelle Suzanne | Director | A Award | 2024-05-30 | 2024-06-03 | 2,783 | — | $0 | 2,783 | SEC↗ |
| Salzmann Peter | Director | A Award | 2024-05-30 | 2024-06-03 | 2,783 | — | $0 | 2,783 | SEC↗ |
| CATLIN AVERY W | Director | A Award | 2024-05-30 | 2024-06-03 | 2,783 | — | $0 | 4,350 | SEC↗ |
| Jenkins John Kenneth | Director | A Award | 2024-05-30 | 2024-06-03 | 2,783 | — | $0 | 2,816 | SEC↗ |
| Altmeyer Anne | Director | A Award deriv | 2024-05-16 | 2024-05-20 | 2,783 | — | $0 | 2,783 | SEC↗ |
| Ben Yong | Director | A Award deriv | 2024-05-16 | 2024-05-20 | 2,783 | — | $0 | 2,783 | SEC↗ |
| CATLIN AVERY W | Director | A Award deriv | 2024-05-16 | 2024-05-20 | 2,783 | — | $0 | 2,783 | SEC↗ |
| HOLMER ALAN F | Director | A Award deriv | 2024-05-16 | 2024-05-20 | 2,783 | — | $0 | 2,783 | SEC↗ |
| Jacques Rachelle Suzanne | Director | A Award deriv | 2024-05-16 | 2024-05-20 | 2,783 | — | $0 | 2,783 | SEC↗ |
| Jenkins John Kenneth | Director | A Award deriv | 2024-05-16 | 2024-05-20 | 2,783 | — | $0 | 2,783 | SEC↗ |
| Salzmann Peter | Director | A Award deriv | 2024-05-16 | 2024-05-20 | 2,783 | — | $0 | 2,783 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | M Exercise deriv | 2024-04-10 | 2024-04-11 | 1,787 | — | $0 | 0 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | M Exercise | 2024-04-10 | 2024-04-11 | 1,787 | $30.00 | $53.6K | 48,605 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-03-08 | 2024-03-11 | 29,342 | $41.23 | $1.21M | 1,754,342 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-03-08 | 2024-03-11 | 156,597 | $45.26 | $7.09M | 2,016,138 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-03-08 | 2024-03-11 | 8,862 | $45.96 | $407.3K | 2,025,000 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-03-08 | 2024-03-11 | 18,548 | $43.26 | $802.4K | 1,797,873 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-03-08 | 2024-03-11 | 61,668 | $44.62 | $2.75M | 1,859,541 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-03-08 | 2024-03-11 | 24,983 | $42.25 | $1.06M | 1,779,325 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-03-07 | 2024-03-11 | 102,140 | $41.23 | $4.21M | 1,725,000 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-03-07 | 2024-03-11 | 46,799 | $37.82 | $1.77M | 1,521,799 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-03-07 | 2024-03-11 | 10,736 | $39.13 | $420.1K | 1,532,535 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-03-07 | 2024-03-11 | 90,325 | $39.99 | $3.61M | 1,622,860 | SEC↗ |
| Smethurst Dominic | Chief Medical Officer | A Award deriv | 2024-02-27 | 2024-02-29 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Smethurst Dominic | Chief Medical Officer | A Award | 2024-02-27 | 2024-02-29 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | A Award deriv | 2024-02-12 | 2024-02-14 | 73,947 | — | $0 | 73,947 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | A Award deriv | 2024-02-12 | 2024-02-14 | 40,176 | — | $0 | 40,176 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | A Award | 2024-02-12 | 2024-02-14 | 73,947 | — | $0 | 84,400 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | A Award | 2024-02-12 | 2024-02-14 | 40,176 | — | $0 | 46,818 | SEC↗ |
| Cormorant Asset Management, LP | 10% Owner | P Buy | 2024-02-02 | 2024-02-06 | 750,000 | $19.00 | $14.25M | 1,475,000 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | M Exercise deriv | 2024-01-26 | 2024-01-30 | 7,179 | $4.97 | $35.7K | 0 | SEC↗ |
| HOLMER ALAN F | Director | M Exercise deriv | 2024-01-26 | 2024-01-30 | 629 | $4.97 | $3.1K | 0 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-01-26 | 2024-01-30 | 16,484 | $36.53 | $602.2K | 678,046 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-01-26 | 2024-01-30 | 32,295 | $35.83 | $1.16M | 661,562 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-01-26 | 2024-01-30 | 31,549 | $34.62 | $1.09M | 629,267 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-01-26 | 2024-01-30 | 18,055 | $33.71 | $608.6K | 597,718 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-01-26 | 2024-01-30 | 3,866 | $32.47 | $125.5K | 579,663 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-01-26 | 2024-01-30 | 4,125 | $31.86 | $131.4K | 575,797 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-01-26 | 2024-01-30 | 2,654 | $31.00 | $82.3K | 571,672 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-01-26 | 2024-01-30 | 43,754 | $37.49 | $1.64M | 721,800 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-01-26 | 2024-01-30 | 3,200 | $38.49 | $123.2K | 725,000 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-01-26 | 2024-01-30 | 29,244 | $29.42 | $860.4K | 569,018 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-01-26 | 2024-01-30 | 14,388 | $25.73 | $370.2K | 456,756 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-01-26 | 2024-01-30 | 15,243 | $26.66 | $406.4K | 471,999 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-01-26 | 2024-01-30 | 36,747 | $27.70 | $1.02M | 508,746 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2024-01-26 | 2024-01-30 | 31,028 | $28.82 | $894.2K | 539,774 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | M Exercise | 2024-01-26 | 2024-01-30 | 7,179 | $4.97 | $35.7K | 7,179 | SEC↗ |
| HOLMER ALAN F | Director | M Exercise | 2024-01-26 | 2024-01-30 | 629 | $4.97 | $3.1K | 1,379 | SEC↗ |
| CATLIN AVERY W | Director | A Award deriv | 2023-05-18 | 2023-05-22 | 5,300 | — | $0 | 5,300 | SEC↗ |
| Ben Yong | Director | A Award deriv | 2023-05-18 | 2023-05-22 | 5,300 | — | $0 | 5,300 | SEC↗ |
| HOLMER ALAN F | Director | A Award deriv | 2023-05-18 | 2023-05-22 | 5,300 | — | $0 | 5,300 | SEC↗ |
| Salzmann Peter | Director | A Award deriv | 2023-05-18 | 2023-05-22 | 5,300 | — | $0 | 5,300 | SEC↗ |
| Jacques Rachelle Suzanne | Director | A Award deriv | 2023-05-18 | 2023-05-22 | 5,300 | — | $0 | 5,300 | SEC↗ |
| Jenkins John Kenneth | Director | A Award deriv | 2023-05-18 | 2023-05-22 | 5,300 | — | $0 | 5,300 | SEC↗ |
| Altmeyer Anne | Director | A Award deriv | 2023-05-18 | 2023-05-22 | 5,300 | — | $0 | 5,300 | SEC↗ |
| Ben Yong | Director | A Award deriv | 2023-03-06 | 2023-03-07 | 5,307 | — | $0 | 5,307 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | A Award deriv | 2023-02-13 | 2023-02-15 | 1,989,546 | — | $0 | 1,949,546 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | A Award deriv | 2023-02-13 | 2023-02-15 | 934,645 | — | $0 | 934,645 | SEC↗ |
| Millian Craig Stuart | Chief Operating Officer | A Award deriv | 2023-02-13 | 2023-02-15 | 934,645 | — | $0 | 934,645 | SEC↗ |
| Brake Rachael Louise | Chief Scientific Officer | A Award deriv | 2023-02-13 | 2023-02-15 | 1,400,000 | — | $0 | 1,400,000 | SEC↗ |
| Altmeyer Anne | Director | A Award deriv | 2022-09-26 | 2022-09-28 | 159,200 | — | $0 | 159,200 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | P Buy | 2022-08-10 | 2022-08-10 | 20,000 | $0.26 | $5.2K | 199,272 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | P Buy | 2022-08-10 | 2022-08-11 | 3,800 | $0.26 | $988 | 98,230 | SEC↗ |
| Millian Craig Stuart | Chief Operating Officer | P Buy | 2022-08-10 | 2022-08-12 | 5,000 | $0.25 | $1.3K | 27,000 | SEC↗ |
| CATLIN AVERY W | Director | A Award deriv | 2022-05-18 | 2022-05-19 | 79,600 | — | $0 | 79,600 | SEC↗ |
| Salzmann Peter | Director | A Award deriv | 2022-05-18 | 2022-05-19 | 79,600 | — | $0 | 79,600 | SEC↗ |
| Jenkins John Kenneth | Director | A Award deriv | 2022-05-18 | 2022-05-19 | 79,600 | — | $0 | 79,600 | SEC↗ |
| HOLMER ALAN F | Director | A Award deriv | 2022-05-18 | 2022-05-19 | 79,600 | — | $0 | 79,600 | SEC↗ |
| Jacques Rachelle Suzanne | Director | A Award deriv | 2022-05-18 | 2022-05-19 | 79,600 | — | $0 | 79,600 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | P Buy | 2022-05-16 | 2022-05-16 | 10,500 | $0.25 | $2.6K | 94,430 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | P Buy | 2022-05-16 | 2022-05-16 | 12,000 | $0.30 | $3.6K | 179,272 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | P Buy | 2022-03-10 | 2022-03-10 | 15,000 | $0.37 | $5.5K | 167,272 | SEC↗ |
| Millian Craig Stuart | Chief Operating Officer | P Buy | 2022-03-10 | 2022-03-11 | 10,000 | $0.37 | $3.7K | 22,000 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | P Buy | 2022-03-09 | 2022-03-09 | 8,600 | $0.37 | $3.2K | 83,930 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | A Award deriv | 2022-02-01 | 2022-02-02 | 538,400 | — | $0 | 538,400 | SEC↗ |
| Brake Rachael Louise | Chief Scientific Officer | A Award deriv | 2022-02-01 | 2022-02-02 | 570,800 | — | $0 | 570,800 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | A Award deriv | 2022-02-01 | 2022-02-02 | 1,489,700 | — | $0 | 1,489,700 | SEC↗ |
| Millian Craig Stuart | Chief Operating Officer | A Award deriv | 2022-02-01 | 2022-02-02 | 402,900 | — | $0 | 402,900 | SEC↗ |
| Brake Rachael Louise | Chief Scientific Officer | A Award deriv | 2021-12-06 | 2021-12-08 | 500,000 | — | $0 | 500,000 | SEC↗ |
| CATLIN AVERY W | Director | A Award deriv | 2021-06-17 | 2021-06-17 | 58,200 | — | $0 | 58,200 | SEC↗ |
| CATLIN AVERY W | Director | A Award deriv | 2021-06-17 | 2021-06-17 | 58,200 | — | $0 | 58,200 | SEC↗ |
| HOLMER ALAN F | Director | A Award deriv | 2021-06-17 | 2021-06-17 | 58,200 | — | $0 | 58,200 | SEC↗ |
| HOLMER ALAN F | Director | A Award deriv | 2021-06-17 | 2021-06-17 | 58,200 | — | $0 | 58,200 | SEC↗ |
| Jacques Rachelle Suzanne | Director | A Award deriv | 2021-06-17 | 2021-06-17 | 58,200 | — | $0 | 58,200 | SEC↗ |
| Jacques Rachelle Suzanne | Director | A Award deriv | 2021-06-17 | 2021-06-17 | 58,200 | — | $0 | 58,200 | SEC↗ |
| Jenkins John Kenneth | Director | A Award deriv | 2021-06-17 | 2021-06-17 | 58,200 | — | $0 | 58,200 | SEC↗ |
| Jenkins John Kenneth | Director | A Award deriv | 2021-06-17 | 2021-06-17 | 58,200 | — | $0 | 58,200 | SEC↗ |
| Salzmann Peter | Director | A Award deriv | 2021-06-17 | 2021-06-17 | 58,200 | — | $0 | 58,200 | SEC↗ |
| Salzmann Peter | Director | A Award deriv | 2021-06-17 | 2021-06-17 | 58,200 | — | $0 | 58,200 | SEC↗ |
| White Barbara | Chief Medical Officer | A Award deriv | 2021-02-02 | 2021-02-04 | 307,300 | — | $0 | 307,300 | SEC↗ |
| White Barbara | Chief Medical Officer | A Award deriv | 2021-02-02 | 2021-02-04 | 307,300 | — | $0 | 307,300 | SEC↗ |
| Millian Craig Stuart | Chief Commercial Officer | A Award deriv | 2021-02-02 | 2021-02-04 | 307,300 | — | $0 | 307,300 | SEC↗ |
| Millian Craig Stuart | Chief Commercial Officer | A Award deriv | 2021-02-02 | 2021-02-04 | 307,300 | — | $0 | 307,300 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | A Award deriv | 2021-02-02 | 2021-02-04 | 956,500 | — | $0 | 956,500 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | A Award deriv | 2021-02-02 | 2021-02-04 | 956,500 | — | $0 | 956,500 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | A Award deriv | 2021-02-02 | 2021-02-04 | 307,300 | — | $0 | 307,300 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | A Award deriv | 2021-02-02 | 2021-02-04 | 307,300 | — | $0 | 307,300 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | M Exercise deriv | 2020-12-21 | 2020-12-22 | 87,500 | $1.40 | $122.5K | 87,500 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | S Sale | 2020-12-21 | 2020-12-22 | 87,500 | $1.75 | $153.1K | 349,610 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | M Exercise | 2020-12-21 | 2020-12-22 | 87,500 | $1.40 | $122.5K | 437,110 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | M Exercise deriv | 2020-12-18 | 2020-12-22 | 53,610 | $1.00 | $53.6K | 53,610 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | M Exercise | 2020-12-18 | 2020-12-22 | 53,610 | $1.00 | $53.6K | 403,220 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | S Sale | 2020-12-18 | 2020-12-22 | 53,610 | $1.40 | $75.1K | 349,610 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | M Exercise deriv | 2020-12-16 | 2020-12-18 | 36,923 | $0.17 | $6.3K | 36,923 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | S Sale | 2020-12-16 | 2020-12-18 | 36,923 | $1.32 | $48.7K | 349,610 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | M Exercise | 2020-12-16 | 2020-12-18 | 36,923 | $0.17 | $6.3K | 386,533 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | P Buy | 2020-11-11 | 2020-11-12 | 4,240 | $1.21 | $5.1K | 75,330 | SEC↗ |
| Golumbeski George | Director | A Award deriv | 2020-07-06 | 2020-07-08 | 81,000 | — | $0 | 81,000 | SEC↗ |
| Salzmann Peter | Director | A Award deriv | 2020-05-20 | 2020-05-22 | 40,500 | — | $0 | 40,500 | SEC↗ |
| CATLIN AVERY W | Director | A Award deriv | 2020-05-20 | 2020-05-22 | 40,500 | — | $0 | 40,500 | SEC↗ |
| Jenkins John Kenneth | Director | A Award deriv | 2020-05-20 | 2020-05-22 | 40,500 | — | $0 | 40,500 | SEC↗ |
| Jacques Rachelle Suzanne | Director | A Award deriv | 2020-05-20 | 2020-05-22 | 40,500 | — | $0 | 40,500 | SEC↗ |
| HOLMER ALAN F | Director | A Award deriv | 2020-05-20 | 2020-05-22 | 40,500 | — | $0 | 40,500 | SEC↗ |
| Hochman David P | Director | A Award deriv | 2020-05-20 | 2020-05-22 | 40,500 | — | $0 | 40,500 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | P Buy | 2020-03-17 | 2020-03-17 | 4,300 | $3.49 | $15.0K | 71,090 | SEC↗ |
| White Barbara | Chief Medical Officer | P Buy | 2020-03-17 | 2020-03-18 | 15,606 | $3.63 | $56.6K | 206,217 | SEC↗ |
| Discordia Robert Paul | Chief Operating Officer | P Buy | 2020-03-17 | 2020-03-18 | 2,840 | $3.54 | $10.1K | 35,490 | SEC↗ |
| Millian Craig Stuart | Chief Commercial Officer | P Buy | 2020-03-17 | 2020-03-18 | 2,000 | $4.25 | $8.5K | 12,000 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | A Award deriv | 2020-03-06 | 2020-03-09 | 226,000 | — | $0 | 226,000 | SEC↗ |
| White Barbara | Chief Medical Officer | A Award deriv | 2020-03-06 | 2020-03-09 | 226,000 | — | $0 | 226,000 | SEC↗ |
| Discordia Robert Paul | Chief Operating Officer | A Award deriv | 2020-03-06 | 2020-03-09 | 226,000 | — | $0 | 226,000 | SEC↗ |
| Millian Craig Stuart | Chief Commercial Officer | A Award deriv | 2020-03-06 | 2020-03-09 | 226,000 | — | $0 | 226,000 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | A Award deriv | 2020-03-06 | 2020-03-09 | 639,000 | — | $0 | 639,000 | SEC↗ |
| Salzmann Peter | Director | A Award deriv | 2020-03-06 | 2020-03-10 | 66,600 | — | $0 | 66,600 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | P Buy | 2019-11-12 | 2019-11-12 | 1,430 | $4.26 | $6.1K | 66,790 | SEC↗ |
| White Barbara | Chief Medical Officer | P Buy | 2019-11-12 | 2019-11-13 | 3,424 | $4.38 | $15.0K | 190,611 | SEC↗ |
| Discordia Robert Paul | Chief Operating Officer | P Buy | 2019-11-11 | 2019-11-12 | 2,500 | $4.62 | $11.6K | 32,650 | SEC↗ |
| Millian Craig Stuart | Chief Commercial Officer | P Buy | 2019-11-11 | 2019-11-12 | 1,000 | $4.38 | $4.4K | 10,000 | SEC↗ |
| Millian Craig Stuart | Chief Commercial Officer | P Buy | 2019-08-15 | 2019-08-16 | 1,500 | $5.48 | $8.2K | 9,000 | SEC↗ |
| Discordia Robert Paul | Chief Operating Officer | P Buy | 2019-08-12 | 2019-08-12 | 15,000 | $5.86 | $87.9K | 30,150 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | P Buy | 2019-08-12 | 2019-08-12 | 1,175 | $6.06 | $7.1K | 65,360 | SEC↗ |
| Millian Craig Stuart | Chief Commercial Officer | P Buy | 2019-08-12 | 2019-08-13 | 1,500 | $6.00 | $9.0K | 7,500 | SEC↗ |
| White Barbara | Chief Medical Officer | P Buy | 2019-08-12 | 2019-08-13 | 1,639 | $6.10 | $10.0K | 187,187 | SEC↗ |
| Discordia Robert Paul | Chief Operating Officer | A Award deriv | 2019-08-06 | 2019-08-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CATLIN AVERY W | Director | A Award deriv | 2019-05-22 | 2019-06-28 | 33,300 | — | $0 | 33,300 | SEC↗ |
| Hochman David P | Director | A Award deriv | 2019-05-22 | 2019-06-28 | 33,300 | — | $0 | 33,300 | SEC↗ |
| HOLMER ALAN F | Director | A Award deriv | 2019-05-22 | 2019-06-28 | 33,300 | — | $0 | 33,300 | SEC↗ |
| Jacques Rachelle Suzanne | Director | A Award deriv | 2019-05-22 | 2019-06-28 | 33,300 | — | $0 | 33,300 | SEC↗ |
| Jenkins John Kenneth | Director | A Award deriv | 2019-05-22 | 2019-06-28 | 33,300 | — | $0 | 33,300 | SEC↗ |
| Panayiotopoulos Paris | Director | A Award deriv | 2019-05-22 | 2019-06-28 | 33,300 | — | $0 | 33,300 | SEC↗ |
| White Barbara | Chief Medical Officer | P Buy | 2019-05-17 | 2019-05-20 | 1,389 | $7.20 | $10.0K | 185,548 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | P Buy | 2019-05-14 | 2019-05-14 | 100 | $7.12 | $712 | 349,610 | SEC↗ |
| Millian Craig Stuart | Chief Commercial Officer | P Buy | 2019-05-14 | 2019-05-15 | 1,000 | $7.23 | $7.2K | 6,000 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | P Buy | 2019-05-13 | 2019-05-14 | 995 | $6.99 | $7.0K | 64,185 | SEC↗ |
| Jacques Rachelle Suzanne | Director | A Award deriv | 2019-04-05 | 2019-04-08 | 68,000 | — | $0 | 68,000 | SEC↗ |
| Jenkins John Kenneth | Director | P Buy | 2019-03-15 | 2019-03-15 | 1,000 | $6.98 | $7.0K | 1,000 | SEC↗ |
| Hochman David P | Director | P Buy | 2019-03-15 | 2019-03-18 | 2,000 | $6.98 | $14.0K | 7,000 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | P Buy | 2019-03-14 | 2019-03-14 | 1,530 | $6.49 | $9.9K | 63,190 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | P Buy | 2019-03-14 | 2019-03-14 | 1,500 | $6.67 | $10.0K | 349,510 | SEC↗ |
| White Barbara | Chief Medical Officer | P Buy | 2019-03-14 | 2019-03-14 | 4,638 | $6.47 | $30.0K | 184,159 | SEC↗ |
| Millian Craig Stuart | Chief Commercial Officer | P Buy | 2019-03-14 | 2019-03-15 | 5,000 | $6.85 | $34.3K | 5,000 | SEC↗ |
| Millian Craig Stuart | Chief Commercial Officer | A Award deriv | 2019-02-28 | 2019-03-04 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | A Award deriv | 2019-01-18 | 2019-01-18 | 195,000 | — | $0 | 195,000 | SEC↗ |
| Tepper Mark | President and CSO | A Award deriv | 2019-01-18 | 2019-01-18 | 195,000 | — | $0 | 195,000 | SEC↗ |
| White Barbara | Chief Medical Officer | A Award deriv | 2019-01-18 | 2019-01-18 | 195,000 | — | $0 | 195,000 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | A Award deriv | 2019-01-18 | 2019-01-18 | 565,000 | — | $0 | 565,000 | SEC↗ |
| Tepper Mark | President and CSO | M Exercise deriv | 2018-11-14 | 2018-11-16 | 10,000 | — | $0 | 261,600 | SEC↗ |
| Tepper Mark | President and CSO | M Exercise | 2018-11-14 | 2018-11-16 | 10,000 | $1.00 | $10.0K | 2,110,400 | SEC↗ |
| Jenkins John Kenneth | Director | A Award deriv | 2018-06-05 | 2018-06-06 | 68,000 | — | $0 | 68,000 | SEC↗ |
| CATLIN AVERY W | Director | A Award deriv | 2018-05-24 | 2018-05-29 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Hochman David P | Director | A Award deriv | 2018-05-24 | 2018-05-29 | 34,000 | — | $0 | 34,000 | SEC↗ |
| HOLMER ALAN F | Director | A Award deriv | 2018-05-24 | 2018-05-29 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Panayiotopoulos Paris | Director | A Award deriv | 2018-05-24 | 2018-05-29 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Hochman David P | Director | G Gift | 2018-05-24 | 2018-05-29 | 110,000 | — | $0 | 110,000 | SEC↗ |
| Hochman David P | Director | G Gift | 2018-05-24 | 2018-05-29 | 220,000 | — | $0 | 0 | SEC↗ |
| Hochman David P | Director | G Gift | 2018-05-24 | 2018-05-29 | 110,000 | — | $0 | 120,000 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | P Buy | 2018-05-15 | 2018-05-15 | 4,000 | $5.77 | $23.1K | 348,010 | SEC↗ |
| Cohen Yuval | Chief Executive Officer | P Buy | 2018-05-15 | 2018-05-16 | 1,725 | $5.85 | $10.1K | 61,660 | SEC↗ |
| White Barbara | Chief Medical Officer | P Buy | 2018-05-15 | 2018-05-16 | 2,586 | $5.87 | $15.2K | 179,521 | SEC↗ |
| Hochman David P | Director | P Buy | 2018-05-14 | 2018-05-15 | 5,000 | $5.48 | $27.4K | 5,000 | SEC↗ |
| Moran Sean F. | Chief Financial Officer | P Buy | 2018-03-14 | 2018-03-14 | 3,100 | $6.60 | $20.5K | 344,010 | SEC↗ |